Literature DB >> 17095347

Hearing loss in Turner syndrome.

Noriko Morimoto1, Toshiaki Tanaka, Hidenobu Taiji, Reiko Horikawa, Yasuhiro Naiki, Yuji Morimoto, Nobuko Kawashiro.   

Abstract

OBJECTIVE: To address the characteristics of hearing loss in patients with Turner syndrome (TS), we evaluated hearing levels of patients with TS and analyzed causative factors. STUDY
DESIGN: Thirty-three patients with TS (8 to 40 years of age) were studied through the use of audiological measurements, and causative factors were explored.
RESULTS: Twenty cases (35 of 66 ears tested) showed high-frequency (8 kHz) sensory neural hearing loss (HFQ-SNHL). Fifteen cases (26 ears) and 15 cases (24 ears) of the impaired 20 cases were unresponsive to distortion-product otoacoustic emissions and transient-evoked otoacoustic emissions, respectively. HFQ-SNHL showed little relation to the history of middle ear infection and puberty, although middle ear infections were seen in 11 of the 20 cases. The hearing thresholds at high frequencies were correlated with age and body height (P < .001). The age-dependent increase in hearing thresholds in the high frequencies was more apparent in patients with TS with monosomic 45, X than in those with the mosaic type (P < .05).
CONCLUSIONS: More than 60% of patients with TS had HFQ-SNHL. Because the increase in hearing threshold at high frequencies was shown to depend on karyotype and aging, regular otological examination is important for the determination of proper treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17095347     DOI: 10.1016/j.jpeds.2006.06.071

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome.

Authors:  Marsha L Davenport; Jackson Roush; Chunhua Liu; Anthony J Zagar; Erica Eugster; Sharon Travers; Patricia Y Fechner; Charmian A Quigley
Journal:  Horm Res Paediatr       Date:  2010-04-27       Impact factor: 2.852

2.  Hearing disorders in Turner's syndrome: a survey from Iran.

Authors:  Mehdi Bakhshaee; Rahim Vakili; Navid Nourizadeh; Mohsen Rajati; Asma Ahrari; Rahman Movahed
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-23       Impact factor: 2.503

3.  Otolaryngologic markers for the early diagnosis of Turner syndrome.

Authors:  Tomoko Makishima; Kelly King; Carmen C Brewer; Christopher K Zalewski; John Butman; Vladimir K Bakalov; Carolyn Bondy; Andrew J Griffith
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-09-03       Impact factor: 1.675

Review 4.  Malformation syndromes associated with disorders of sex development.

Authors:  John M Hutson; Sonia R Grover; Michele O'Connell; Samuel D Pennell
Journal:  Nat Rev Endocrinol       Date:  2014-06-10       Impact factor: 43.330

5.  TBL1Y: a new gene involved in syndromic hearing loss.

Authors:  Mariateresa Di Stazio; Chiara Collesi; Diego Vozzi; Wei Liu; Mike Myers; Anna Morgan; Pio Adamo D Adamo; Giorgia Girotto; Elisa Rubinato; Mauro Giacca; Paolo Gasparini
Journal:  Eur J Hum Genet       Date:  2018-10-19       Impact factor: 4.246

6.  Turner syndrome and the evolution of human sexual dimorphism.

Authors:  Bernard Crespi
Journal:  Evol Appl       Date:  2008-02-22       Impact factor: 5.183

7.  Complex X chromosome rearrangement associated with multiorgan autoimmunity.

Authors:  Irén Haltrich; Henriett Pikó; Horolma Pamjav; Anikó Somogyi; Antónia Völgyi; Dezső David; Artúr Beke; Zoltán Garamvölgyi; Eszter Kiss; Veronika Karcagi; György Fekete
Journal:  Mol Cytogenet       Date:  2015-07-19       Impact factor: 2.009

8.  Turner syndrome and associated problems in Turkish children: a multicenter study.

Authors:  Ediz Yeşilkaya; Abdullah Bereket; Feyza Darendeliler; Firdevs Baş; Şükran Poyrazoğlu; Banu Küçükemre Aydın; Şükran Darcan; Bumin Dündar; Muammer Büyükinan; Cengiz Kara; Erkan Sarı; Erdal Adal; Ayşehan Akıncı; Mehmet Emre Atabek; Fatma Demirel; Nurullah Çelik; Behzat Özkan; Bayram Özhan; Zerrin Orbak; Betül Ersoy; Murat Doğan; Ali Ataş; Serap Turan; Damla Gökşen; Ömer Tarım; Bilgin Yüksel; Oya Ercan; Şükrü Hatun; Enver Şimşek; Ayşenur Ökten; Ayhan Abacı; Hakan Döneray; Mehmet Nuri Özbek; Mehmet Keskin; Hasan Önal; Nesibe Akyürek; Kezban Bulan; Derya Tepe; Hamdi Cihan Emeksiz; Korcan Demir; Deniz Kızılay; Ali Kemal Topaloğlu; Erdal Eren; Samim Özen; Saygın Abalı; Leyla Akın; Beray Selver Eklioğlu; Sultan Kaba; Ahmet Anık; Serpil Baş; Tolga Ünüvar; Halil Sağlam; Semih Bolu; Tolga Özgen; Durmuş Doğan; Esra Deniz Çakır; Yaşar Şen; Nesibe Andıran; Filiz Çizmecioğlu; Olcay Evliyaoğlu; Gülay Karagüzel; Özgür Pirgon; Gönül Çatlı; Hatice Dilek Can; Fatih Gürbüz; Çiğdem Binay; Veysel Nijat Baş; Kürşat Fidancı; Adem Polat; Davut Gül; Cengizhan Açıkel; Hüseyin Demirbilek; Peyami Cinaz; Carolyn Bondy
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-03

9.  DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations.

Authors:  Amit Sharma; Muhammad Ahmer Jamil; Nicole Nuesgen; Felix Schreiner; Lutz Priebe; Per Hoffmann; Stefan Herns; Markus M Nöthen; Holger Fröhlich; Johannes Oldenburg; Joachim Woelfle; Osman El-Maarri
Journal:  Clin Epigenetics       Date:  2015-07-28       Impact factor: 6.551

10.  Management of Turner Syndrome.

Authors:  Aneta Gawlik
Journal:  Eur Endocrinol       Date:  2015-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.